You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
PD-1/PD-L1 Inhibitors in Cervical Cancer
|
|---|---|
| Published in |
Frontiers in Pharmacology, February 2019
|
| DOI | 10.3389/fphar.2019.00065 |
| Pubmed ID | |
| Authors |
Yuncong Liu, Li Wu, Ruizhan Tong, Feiyue Yang, Limei Yin, Mengqian Li, Liting You, Jianxin Xue, You Lu |
X Demographics
The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 12% |
| South Africa | 1 | 4% |
| Germany | 1 | 4% |
| United Kingdom | 1 | 4% |
| Finland | 1 | 4% |
| Austria | 1 | 4% |
| Unknown | 17 | 68% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 72% |
| Practitioners (doctors, other healthcare professionals) | 3 | 12% |
| Science communicators (journalists, bloggers, editors) | 2 | 8% |
| Scientists | 2 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 146 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 20 | 14% |
| Student > Bachelor | 13 | 9% |
| Student > Master | 12 | 8% |
| Researcher | 11 | 8% |
| Student > Doctoral Student | 8 | 5% |
| Other | 26 | 18% |
| Unknown | 56 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 24% |
| Biochemistry, Genetics and Molecular Biology | 18 | 12% |
| Immunology and Microbiology | 7 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Agricultural and Biological Sciences | 5 | 3% |
| Other | 9 | 6% |
| Unknown | 65 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2019.
All research outputs
#2,868,983
of 25,789,020 outputs
Outputs from Frontiers in Pharmacology
#1,250
of 20,010 outputs
Outputs of similar age
#65,249
of 450,234 outputs
Outputs of similar age from Frontiers in Pharmacology
#29
of 307 outputs
Altmetric has tracked 25,789,020 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,010 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,234 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 307 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.